APN Results Bullish
ASPEN PHARMACARE HOLDINGS LIMITED - Unaudited condensed interim Group financial results for the six months ended 31 December 2025
Aspen Pharmacare Holdings Limited
Free preview
What this filing means
Aspen reported a transitional H1 2026 with a 35% HEPS decline due to restructuring and mRNA contract losses, but maintains guidance for double-digit FY 2026 growth and significant debt elimination via the APAC divestment.
Bull case
- Commercial Pharmaceuticals, the Group's core segment, delivered robust 11% normalised EBITDA growth at constant exchange rates (CER), supported by strong demand for Mounjaro®.
- The APAC Divestment of AUD 2.37 billion is expected to effectively eliminate most of the Group's net debt, drastically improving balance sheet flexibility.
Bear case
- Headline earnings per share (HEPS) fell 35% to 417.4 cents, heavily impacted by R695 million in restructuring costs and the loss of the mRNA contract.
Unlock the full analysis
Free during launch. Sign in to read the complete breakdown.
- Full bull / bear breakdown
- Decision framework
- Citations & sources
- Price autopsy
Related filings
More from APN
- ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122 (3)(b) of the Companies Act and Section 6.54 of the JSE Listings Requirements
- ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Prescribed Officer
- ASPEN PHARMACARE HOLDINGS LIMITED - Change in Chairmanship of the Audit and Risk Committee
- ASPEN PHARMACARE HOLDINGS LIMITED - Completion of the divestment of Aspen APAC
- ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director and Prescribed Officer
Other Results
- SLGSALUNGANO GROUP LIMITED - Audited Consolidated Financial Results for the Year ended 31 March 2026
- SKASHUKA MINERALS PLC - Short Form SENS Announcement - Audited Financial Statements for the Year Ended 31 December 2025
- GOLDRUSH HOLDINGS LIMITED - Audited Consolidated Annual Financial Results for the year ended 31 March 2026 and BBBEE Annual Compliance Report
- ARTARGENT INDUSTRIAL LIMITED - Audited results for the year ended 31 March 2026, dividend declaration, notice of AGM, distribution of annual report
- PRXPROSUS N.V - Annual results announcement for the year ended 31 March 2026